News & Events
22 May 2019
Juan Luis Musoles joins HEROES project
Juan Luis Musoles joined the HEROES project on January 2019 as a technician in Dr. Dierssen’s lab (Partner 1). Juan Luis has a bachelor’s degree in Biochemistry and Biomedical Sciences. He is involved in the histological analysis of the noradrenergic system of mouse models of neurodegenerative diseases. He combines stereological counting of noradrenergic neurons in the main noradrenergic nu...
03 May 2019
Sue Noy joins HEROES project
Sue Noy was joined to HEROES project on September 2018. Sue is a member of the LonDownS Consortium mouse work stream and is involved in phenotyping novel mouse models of DS and AD-DS neurodegeneration using a range of immunohistochemical techniques. Sue read Zoology and Human Physiology at the University of London and completed a Ph.D in invertebrate neuroscience studying the distribution and c...
29 April 2019
World Down Syndrome Day Celebration 2019 by LonDownS Consortium
HEROES partners from UK organized and participated on several activities in the World Down Syndrome Day. This is the third year that the LonDownS Consortium celebrates World Down Syndrome Day with a science communication event for people who have Down syndrome, their families and carers. The event, hosted in the state-of-the-art Francis Crick Institute in London on 21st of March , had three goa...
15 April 2019
Marta Fructuoso joins HEROES project
Marta Fructuoso joined the HEROES project on February 2018 as a postdoctoral researcher in Dr. Poitier’s team (Partner 2). Her research aims at investigating whether a defect in the endo-lysosomal pathway in neurons from the locus coeruleus may be a shared mechanism contributing to dementia in neurodegenerative diseases such as Alzheimer disease, Parkinson disease, and Down syndrome. She will...
15 April 2019
Maartje de Vries joins HEROES project
Maartje de Vries, MSc joined the HEROES project on October 2018 as a PhD student at the University Medical Center Groningen (UMCG) Alzheimer Center in the Netherlands (Partner 4; lead by Prof. Dr. P. De Deyn). She will be involved in performing neuroimaging in patients, using positron emission tomography (PET) to characterize the noradrenergic system in vivo. Since evidence shows that noradrene...